Earth Science Tech, INC 8-K filings

Earth Science Tech, Inc. announced the acquisition of Meduvo LLC, a California compounding pharmacy, to establish a West Coast hub and expand its operational reach.

Earth Science Tech, Inc. announced robust fiscal first quarter 2027 results, marked by a 57% surge in net income and a 108% increase in operating cash flow.

Earth Science Tech, Inc. announced its fiscal year-end financial results for March 31, 2026, reporting an 8% increase in revenue to $35.7 million and a 11% rise in net income to $3.6 million.

Earth Science Tech, Inc. released its annual shareholder letter for FY ended March 31, 2026, detailing significant operational achievements and a debt-free growth strategy.

Earth Science Tech, Inc. has amended its bylaws to permit the delivery of shareholder meeting notices via electronic transmission.

Earth Science Tech, Inc. announced the launch of MyOnlineConsultation.com, completing its vertically integrated telehealth and pharmacy ecosystem and achieving cash-flow positive status during its beta phase.

Earth Science Tech, Inc. announced the one-year renewal of employment agreements for its Chief Financial Officer and Chief Technology Officer, maintaining continuity in key leadership roles.

Earth Science Tech, Inc. announced robust third fiscal quarter 2026 results with significant net income growth and outlined strategic initiatives to enhance corporate governance and achieve $1.4 million in annualized savings.

Earth Science Tech, Inc. formally directs financial data providers to update its industry classification to SIC 2834, reflecting its pharmaceutical operations since 2022.

Earth Science Tech, Inc. announced its engagement with Hayden IR to enhance investor relations, following a strong first half of fiscal 2026 with $17.8 million in revenue and 70%+ gross margins.

Earth Science Tech, Inc. announced significant financial and operational growth for its second fiscal quarter ended September 30, 2025, including a 71.64% increase in total assets.

Earth Science Tech, Inc. has reduced its authorized common stock from 350 million to 300 million shares, effective October 10, 2025.

Earth Science Tech, Inc. announced its Board of Directors approved reducing authorized common stock from 350 million to 300 million shares, signaling confidence and commitment to shareholder value.

Earth Science Tech, Inc. announced significant asset growth and revenue increase in its first fiscal quarter ended June 30, 2025, driven by strategic acquisitions.

Earth Science Tech, Inc. announced its qualification for and listing on the newly launched OTCID tier of the OTC Markets, signaling enhanced disclosure and corporate governance.

Earth Science Tech, Inc. announced robust financial performance for the fiscal year ended March 31, 2025, reporting a 177.05% increase in revenue to $33.1 million and a 300.63% surge in net profit to $3.2 million.

Earth Science Tech, Inc. announces projected record-breaking financial results for the fiscal year ending March 31, 2025, including a 340% increase in net income and a 175% increase in revenue.

Earth Science Tech, Inc. finalizes acquisitions of Las Villas Health Care, Doconsultations.com, Magnefuse, and Alicat, while also announcing a change in its independent registered public accounting firm.

Earth Science Tech, Inc. approves the continuation of employment agreements for its CFO and CTO, maintaining their existing base salaries and bonus eligibility.

Earth Science Tech, Inc. amended its acquisition agreement with Las Villas Healthcare, LLC and Doconsultations.com, LLC, reducing the purchase price from $400,000 to $200,000.

Earth Science Tech, Inc. announces acquisitions of Las Villas Healthcare, Doconsultations.com, Magnefuse, and Alicat, along with updates on its share repurchase program.

Earth Science Tech has expanded its board of directors, appointed new members, established a compensation committee, and amended executive compensation agreements.

Earth Science Tech, Inc. has completed the acquisition of Avenvi, LLC for $1.058 million, including real estate assets and cash.

Earth Science Tech, Inc. completed two acquisitions, launched a new pet and wildlife brand, and relocated its principal office, all on October 1, 2024.

Earth Science Tech has approved a new compensation plan for its CEO and COO, linking their pay to a percentage of monthly cash receipts and quarterly net profit increases.

Earth Science Tech, Inc. announced that the Quebec Cease Trade Order from December 5th, 2019, has been revoked, and its status changed to Inactive on the Canadian Sedar website.

Earth Science Tech, Inc. announces a successful fiscal year end, highlighted by a 54% revenue increase in the fourth quarter and significant progress across its business segments.

Earth Science Tech, Inc. has appointed Christopher Rose as its new Chief Technology Officer, effective April 16, 2024.

Earth Science Tech, Inc. has appointed Mario G. Tabraue as its new Chief Operations Officer, effective April 9, 2024.

Earth Science Tech, Inc. has appointed Ernesto L. Flores as its new Chief Financial Officer, succeeding Gabrielle Schuster, who resigned on March 3, 2024.